Bunevicius Robertas, Prange Arthur J
Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7160, USA.
CNS Drugs. 2006;20(11):897-909. doi: 10.2165/00023210-200620110-00003.
Graves' disease is an autoimmune disorder that is the most common cause of hyperthyroidism. Other symptoms associated with the disease are goitre, ophthalmopathy, and psychiatric manifestations such as mood and anxiety disorders and, sometimes, cognitive dysfunction. Graves' hyperthyroidism may result in these latter manifestations via the induction of hyperactivity of the adrenergic nervous system. This review addresses the psychiatric presentations, and their pathophysiology and treatment, in patients with hyperthyroidism, based on literature identified by a PubMed/MEDLINE database search. Although the focus is on mental symptoms associated with Graves' disease, it is not always clear from the literature whether patients had Graves' disease: in some studies, the patients were thought to have Graves' disease based on clinical findings such as diffuse goitre or ophthalmopathy or on measurements of thyroid antibodies in serum; however, in other studies, no distinction was made between Graves' hyperthyroidism and hyperthyroidism from other causes. Antithyroid drugs combined with beta-adrenoceptor antagonists are the treatments of choice for hyperthyroidism, as well as for the psychiatric disorders and mental symptoms caused by hyperthyroidism. A substantial proportion of patients have an altered mental state even after successful treatment of hyperthyroidism, suggesting that mechanisms other than hyperthyroidism, including the Graves' autoimmune process per se and ophthalmopathy, may also be involved. When psychiatric disorders remain after restoration of euthyroidism and after treatment with beta-adrenoceptor antagonists, specific treatment for the psychiatric symptoms, especially psychotropic drugs, may be needed.
格雷夫斯病是一种自身免疫性疾病,是甲状腺功能亢进最常见的病因。与该疾病相关的其他症状包括甲状腺肿大、眼病以及精神症状,如情绪和焦虑障碍,有时还包括认知功能障碍。格雷夫斯病所致的甲状腺功能亢进可能通过诱导肾上腺素能神经系统功能亢进导致这些后期表现。本综述基于通过PubMed/MEDLINE数据库检索确定的文献,探讨甲状腺功能亢进患者的精神症状表现、其病理生理学及治疗方法。尽管重点是与格雷夫斯病相关的精神症状,但从文献中并不总是能明确患者是否患有格雷夫斯病:在一些研究中,根据弥漫性甲状腺肿大或眼病等临床发现或血清甲状腺抗体检测结果,认为患者患有格雷夫斯病;然而,在其他研究中,并未区分格雷夫斯病所致的甲状腺功能亢进和其他原因所致的甲状腺功能亢进。抗甲状腺药物联合β肾上腺素能受体拮抗剂是治疗甲状腺功能亢进以及由甲状腺功能亢进引起的精神障碍和精神症状的首选药物。相当一部分患者即使在甲状腺功能亢进成功治疗后仍有精神状态改变,这表明除甲状腺功能亢进外的其他机制,包括格雷夫斯病自身免疫过程本身和眼病,可能也参与其中。当甲状腺功能恢复正常且使用β肾上腺素能受体拮抗剂治疗后精神障碍仍然存在时,可能需要针对精神症状进行特异性治疗,尤其是使用精神药物。